latest update:
[TrialBase DB]

trial summary · NCT07664748

Artificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study

AVATAR-HF (Artificial Voice Analysis and Telemonitoring for Heart Failure): Studio di fattibilità Sull'Uso Dell'Analisi Vocale Basata su Intelligenza Artificiale Per il Telemonitoraggio Dei Pazienti Con Insufficienza Cardiaca.

Trial record from the TrialBase DB dataset, status RECRUITING, condition Heart Failure, sponsored by Niguarda Hospital. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07664748phase —enrollment 60start 2026-10-30

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Heart failure is a serious condition and a major reason why older adults are admitted to the hospital. Even after going home, many patients struggle to get the follow-up care they need, leading to high rates of return to the hospital. While remote monitoring technology exists, it is often difficult to use, expensive, or hard for doctors to interpret. Recent research suggests that changes in a person's voice and speech can be early warning signs of worsening heart failure, but we need to test if this can work reliably in a home setting.This study tests a new, user-friendly platform called AVATAR-SC. This system uses a a computer-generated character to interact with patients. By analyzing short voice clips and simple health questionnaires provided by the patient, the system aims to make home monitoring easier and more effective. The study will involve 60 participants divided into two groups:half of the patients who have recently been discharged from the hospital following a heart failure episode; the other 30 patients who visit the hospital monthly for a specific heart failure treatment (Levosimendan). Participants will interact with the digital avatar twice a week. During these sessions, they will provide brief voice recordings and answer a few questions about how they feel. It is important to note that the AI in this study is not making medical decisions or changing the patient's current treatment; it is strictly being tested to see how well the technology functions. As a feasibility study, the primary goal is to evaluate the practical implementation of the technology …

Source record: https://clinicaltrials.gov/study/NCT07664748

Facts

registry idNCT07664748
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionHeart Failure
sponsorNiguarda Hospital
sponsor classOTHER
enrollment60
start date2026-10-30
primary completion2027-05-15
completion2028-05-15
results postednot reported

Conditions

  • Heart Failure

Interventions

  • AVATAR-SC
  • Levosimendan

Countries

  • Italy

Intervention types: DRUG, OTHER

Work with this record